In Missouri, people injured by defective products are allowed to file product liability lawsuits against companies who make those products. Recently, numerous product liability lawsuits have been filed against manufacturers of defective prescription drugs. One such manufacturer is Organon, headquartered in Oss, Netherlands. Organon makes NuvaRing. NuvaRing has been known to cause blood clots, stroke and even death. The basis of these defective drug lawsuits is that Organon knew of serious side effects of NuvaRing, but failed to warn or educate its users of these known side effects. These lawsuits are frequently referred to in Missouri as failure to warn cases.
NuvaRing is a combined vaginal contraceptive and was approved by the Federal Drug Administration (FDA) in 2001. This brand of contraceptive has adverse health effects. Within the past year, numerous lawsuits have been filed against Organon throughout the United States.
As a relatively new “third generation” form of birth control, NuvaRing releases a continuous dose of hormones to prevent pregnancy. It is a flexible ring about 2 inches in diameter and is inserted into the vagina and left in place for three weeks, then removed for a week during which time the user has a menstrual period. The benefits of NuvaRing are touted as convenience, ease of use and exposure to lower levels of estrogen than with “generation two” oral contraceptives or patches. These supposed benefits come with some very serious side effects.
In March of 2008 a New Jersey man filed suit in New Jersey State Court alleging his wife’s death was caused by her use of NuvaRing. Additionally, the husband alleged the makers, marketers and distributors purposely hid this drug’s dangers and health risks.
Two recently conducted clinical studies found 15.1% of women discontinued use of NuvaRing because of adverse side effects.
Deep Vein Thrombosis (DVT) is a blood clot that forms inside a vein deep in the body. When ones blood thickens and clumps together, a blood clot is formed. Deep vein blood clots can occur throughout the human body, but most of them occur in the lower leg or thigh. A loose clot called embolus is the result of a blood clot in a deep vein breaking off and travel throughout the blood stream. When the clot travels into the lungs and blocks blood flow, the resulting condition is called pulmonary embolism (PE). Thus, a blood clot can lead to a breakdown of organs and tissue and has the possibility of ultimately leading to a need for amputation and even death. Many women using the NuvaRing have experienced these serious side effects and have suffered multiple NuvaRing pulmonary embolisms.
The reported side effects have been forcing women to rethink their birth control choices and have doctors questioning whether the NuvaRing label provides a sufficient warning of the risk of blood clots, pulmonary embolism and various other conditions including stroke or heart attack.
Organon cautioned NuvaRing users regarding the symptoms listed below and recommends women taking NuvaRing should immediately call their healthcare provider if they experience any of these symptoms:
The product liability attorneys at E. Ryan Bradley have conducted extensive research about NuvaRing and are aware of its dangers. Our St. Louis defective drug litigation lawyers are accepting new cases involving serious personal injury or death associated with this drug. If you wish to speak to an experienced Missouri product liability lawyer, contact E. Ryan Bradley in St. Louis, Missouri. As always, it is free to speak to our attorneys.
The following website has additional information you may find helpful regarding NuvaRing: